555 related articles for article (PubMed ID: 10918179)
1. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
[TBL] [Abstract][Full Text] [Related]
3. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
4. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
[TBL] [Abstract][Full Text] [Related]
5. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma.
Wagner JD; Davidson D; Coleman JJ; Hutchins G; Schauwecker D; Park HM; Havlik RJ
Ann Surg Oncol; 1999 Jun; 6(4):398-404. PubMed ID: 10379863
[TBL] [Abstract][Full Text] [Related]
6. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
7. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact.
Rutkowski P; Nowecki ZI; Nasierowska-Guttmejer A; Ruka W
Eur J Surg Oncol; 2003 Sep; 29(7):611-8. PubMed ID: 12943629
[TBL] [Abstract][Full Text] [Related]
8. Metastatic area ratio can help predict nonsentinel node positivity in melanoma patients.
Bertolli E; Macedo MP; Pinto CA; Damascena AS; Molina AS; Duprat Neto JP
Melanoma Res; 2016 Feb; 26(1):42-5. PubMed ID: 26397049
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of melanoma features and their relationship with nodal disease: the importance of the pathological report.
Bertolli E; de Macedo MP; Pinto CA; Damascena AS; Molina AS; Ueno PS; Duprat Neto JP
Tumori; 2015; 101(5):501-5. PubMed ID: 25983100
[TBL] [Abstract][Full Text] [Related]
10. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
11. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
12. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
14. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases.
Salti GI; Das Gupta TK
Am J Surg; 2003 Aug; 186(2):98-101. PubMed ID: 12885597
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
[TBL] [Abstract][Full Text] [Related]
16. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
17. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.
Lee NC; Spillane AJ; Pang TC; Haydu LE; Uren RF
Ann Surg Oncol; 2012 Jan; 19(1):280-6. PubMed ID: 21833669
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]